In the context of VHL-deficient hemangioblastomas, the stabilization of both HIF-1α and HIF-2α has been suggested to drive the tumor’s highly vascularized environment, thereby promoting its growth and survival [19,38]. The gene discussed is HIF1A; the disease is hemangioblastoma.